Preliminary study detecting of plasma soluble PD-L1 in the patients with advanced lung cancer
Not Applicable
- Conditions
- lung cancer
- Registration Number
- JPRN-UMIN000014760
- Brief Summary
The implication of soluble PD-L1 (sPD-L1) in lung cancer patients remains unknown. The present study demonstrated that high levels of sPD-L1 was associated with poor prognosis in advanced lung cancer. sPD-L1 may be a useful biomarker for immune checkpoint therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 96
Inclusion Criteria
Not provided
Exclusion Criteria
Other than that above
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method